Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187603 · ClinicalTrials.gov registry record · NA
Protecting the 'Hood Against Tobacco
A NA study of Smoking, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT00187603 is a NA study of Smoking that has completed, run by University of California, San Francisco. The registered enrollment target is 270 participants, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00187603, a NA study of Smoking, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is particularly urgent that researchers focusing on tobacco control partner with African American communities. Intervention strategies which hold the tobacco industry accountable for its behavior are effective in changing views of tobacco use. In earlier work, the investigators found that information from internal tobacco industry documents, when shown to African American smokers, stimulated reflection about quitting and interest in disseminating information about industry targeting behaviors to others. However, to date there have been no attempts to utilize the information in industry documents as part of a smoking cessation intervention. In this project, the investigators will test whether a community co-developed, tailored quit-smoking program featuring exposures to African American-specific tobacco industry documents and media exercises in addition to proven individual quitting strategies can increase the number of people who quit smoking at six months and one year, as compared with usual care. The specific aims of the project are to: 1. test, using statistics, how well an innovative community-based, culturally tailored quit-smoking program for African Americans works at 6 and 12 months; 2. test selected variables for how well they predict who will return to smoking; 3. use interviews to identify additional individual and/or community factors associated with successful quitting or relapse; and 4. collect information to evaluate the overall effectiveness of the CARA project collaborative efforts in developing and sustaining the project over time, enhancing community awareness of tobacco issues, and creation or enhancement of community tobacco control resources.
Conditions Studied
Interventions
- BEHAVIORAL tobacco cessation program
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2003-07 |
| Est. Completion | 2007-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187603
The ClinicalTrials.gov registry entry for NCT00187603 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (40% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which tobacco cessation program is the first listed.
NCT00187603 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00187603 about?
NCT00187603 is a clinical study titled "Protecting the 'Hood Against Tobacco". Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is particularly urgent that researchers focusing on tobacco control partner with African American communities. Interven...
What is the current status of trial NCT00187603?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2003-07. Estimated completion is 2007-06.
What conditions does trial NCT00187603 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT00187603?
The interventions under investigation include: tobacco cessation program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00187603?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00187603 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.